[HTML][HTML] Pharmacogenetics guidelines: overview and comparison of the DPWG, CPIC, CPNDS, and RNPGx guidelines
H Abdullah-Koolmees, AM Van Keulen… - Frontiers in …, 2021 - frontiersin.org
Many studies have shown that the efficacy and risk of side effects of drug treatment is
influenced by genetic variants. Evidence based guidelines are essential for implementing …
influenced by genetic variants. Evidence based guidelines are essential for implementing …
Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future
Background: To highlight the importance of spontaneous reporting programs in post
marketing surveillance of medicines. Authors also aimed at providing various dimensions of …
marketing surveillance of medicines. Authors also aimed at providing various dimensions of …
[HTML][HTML] Pharmacogenomics in practice: A review and implementation guide
Considerable efforts have been exerted to implement Pharmacogenomics (PGx), the study
of interindividual variations in DNA sequence related to drug response, into routine clinical …
of interindividual variations in DNA sequence related to drug response, into routine clinical …
Genomewide association studies in pharmacogenomics
The increasing availability of genotype data linked with information about drug‐response
phenotypes has enabled genomewide association studies (GWAS) that uncover genetic …
phenotypes has enabled genomewide association studies (GWAS) that uncover genetic …
[HTML][HTML] Applying next-generation sequencing platforms for pharmacogenomic testing in clinical practice
Pharmacogenomics (PGx) studies the use of genetic data to optimize drug therapy.
Numerous clinical centers have commenced implementing pharmacogenetic tests in clinical …
Numerous clinical centers have commenced implementing pharmacogenetic tests in clinical …
[HTML][HTML] Pharmacogenomics: A road ahead for precision medicine in psychiatry
Psychiatric genomics is providing insights into the nature of psychiatric conditions that in
time should identify new drug targets and improve patient care. Less attention has been paid …
time should identify new drug targets and improve patient care. Less attention has been paid …
[HTML][HTML] Technologies for pharmacogenomics: a review
The continuous development of new genotyping technologies requires awareness of their
potential advantages and limitations concerning utility for pharmacogenomics (PGx). In this …
potential advantages and limitations concerning utility for pharmacogenomics (PGx). In this …
[HTML][HTML] Circulating biomarkers instead of genotyping to establish metabolizer phenotypes
R Tremmel, U Hofmann, M Haag… - Annual Review of …, 2024 - annualreviews.org
Pharmacogenomics (PGx) enables personalized treatment for the prediction of drug
response and to avoid adverse drug reactions. Currently, PGx mainly relies on the genetic …
response and to avoid adverse drug reactions. Currently, PGx mainly relies on the genetic …
[HTML][HTML] DeamiDATE 1.0: Site-specific deamidation as a tool to assess authenticity of members of ancient proteomes
Contamination is a potential problem in the study of ancient proteins, either from prior
handling of the sample, laboratory consumables, or cross-sample carryover from mass …
handling of the sample, laboratory consumables, or cross-sample carryover from mass …
Applications for pharmacogenomics in pharmacy practice: A scoping review
Abstract Background Pharmacogenomics (PGx) can provide valuable pharmacokinetic and
pharmacodynamic information for the pharmacist's assessment of drug therapy, especially …
pharmacodynamic information for the pharmacist's assessment of drug therapy, especially …